These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 36672827)
1. Identification and Validation of Three m6A Regulators: Sun J; Gan L; Sun J Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672827 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients. Zhang P; Chen H; Xie B; Zhao W; Shang Q; He J; Shen G; Yu X; Zhang Z; Zhu G; Chen G; Yu F; Liang D; Tang J; Cui J; Liu Z; Ren H; Jiang X Front Endocrinol (Lausanne); 2023; 14():990078. PubMed ID: 36967763 [TBL] [Abstract][Full Text] [Related]
3. Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis. Huang G; Huang S; Cui H Front Pharmacol; 2022; 13():993567. PubMed ID: 36518679 [TBL] [Abstract][Full Text] [Related]
4. Significance of RNA N6-Methyladenosine Regulators in the Diagnosis and Subtype Classification of Childhood Asthma Using the Gene Expression Omnibus Database. Dai B; Sun F; Cai X; Li C; Liu H; Shang Y Front Genet; 2021; 12():634162. PubMed ID: 33763115 [TBL] [Abstract][Full Text] [Related]
5. Exploring diagnostic m6A regulators in endometriosis. Jiang L; Zhang M; Wu J; Wang S; Yang X; Yi M; Zhang X; Fang X Aging (Albany NY); 2020 Nov; 12(24):25916-25938. PubMed ID: 33232273 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma. Yu Y; Liang C; Tang Q; Shi Y; Shen L Gene; 2024 Feb; 894():147989. PubMed ID: 37972699 [TBL] [Abstract][Full Text] [Related]
7. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy. Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267 [TBL] [Abstract][Full Text] [Related]
8. A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder. Zheng B; Wang J; Zhao G; Chen X; Yao Z; Niu Z; He W Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779704 [TBL] [Abstract][Full Text] [Related]
9. Construction and validation of m6A-related diagnostic model for psoriasis. Liu J; Wang Y; Sheng Y; Cai L; Wang Y PeerJ; 2024; 12():e17027. PubMed ID: 38436011 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Rheumatoid Arthritis. Zhang S; Sun S; Zhang Y; Liu J; Wu Y; Zhang X Biochem Genet; 2024 Oct; 62(5):3467-3484. PubMed ID: 38112894 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction. Wang X; Wu Y; Guo R; Zhao L; Yan J; Gao C J Immunol Res; 2022; 2022():5173761. PubMed ID: 36061306 [TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma. Wang J; Zuo Y; Lv C; Zhou M; Wan Y IUBMB Life; 2023 Feb; 75(2):137-148. PubMed ID: 36177774 [TBL] [Abstract][Full Text] [Related]
13. Identification of RNA N6-methyladenosine regulation in epilepsy: Significance of the cell death mode, glycometabolism, and drug reactivity. Liu X; Sun Q; Cao Z; Liu W; Zhang H; Xue Z; Zhao J; Feng Y; Zhao F; Wang J; Wang X Front Genet; 2022; 13():1042543. PubMed ID: 36468034 [TBL] [Abstract][Full Text] [Related]
14. Identification and Prognostic Value of m6A-Related Genes in Glioblastoma. Zheng P; Zhang X; Ren D; Bai Q Neurol India; 2024 Jul; 72(4):830-836. PubMed ID: 39216042 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma. Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis. Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449 [TBL] [Abstract][Full Text] [Related]
18. Cross-Talk between N6-Methyladenosine and Their Related RNAs Defined a Signature and Confirmed m6A Regulators for Diagnosis of Endometriosis. Wang X; Zhao X; Wang J; Wu H; Cheng Y; Guo Q; Liang T; Zhang G Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675186 [TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer. Wu J; Wang X; Li X Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224 [TBL] [Abstract][Full Text] [Related]
20. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database. Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]